EA
AGN

Euclid Advisors’s Allergan plc AGN Stock Holding History

Euclid Advisors’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-1,416
Closed -$297K – 17
2016
Q4 		$297K Sell
1,416
-3,038
-68% -$629K 6.2% 2
2016
Q3 		$1.03M Sell
4,454
-61,686
-93% -$15.1M 5.92% 2
2016
Q2 		$15.3M Buy
66,140
+124
+0.2% +$28.6K 0.66% 35
2016
Q1 		$17.7M Sell
66,016
-18,286
-22% -$5.23M 0.67% 35
2015
Q4 		$26.3M Buy
84,302
+63,679
+309% +$19M 0.8% 21
2015
Q3 		$5.61M Sell
20,623
-29,745
-59% -$9.14M 0.25% 124
2015
Q2 		$15.3M Sell
50,368
-99,592
-66% -$29.7M 0.3% 106
2015
Q1 		$44.6M Buy
+149,960
New +$42.8M 0.82% 21
2014
Q4 		– Sell
-142,110
Closed -$34.3M – 528
2014
Q3 		$34.3M Buy
142,110
+9,570
+7% +$2.14M 0.25% 92
2014
Q2 		$29.6M Buy
132,540
+31,072
+31% +$6.43M 0.21% 117
2014
Q1 		$20.9M Buy
101,468
+28,320
+39% +$5.61M 0.16% 135
2013
Q4 		$12.3M Sell
73,148
-3,740
-5% -$585K 0.1% 200
2013
Q3 		$11.1M Buy
76,888
+31,873
+71% +$4.25M 0.11% 191
2013
Q2 		$5.68M Buy
+45,015
New +$5.1M 0.07% 274

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Euclid Advisors's AGN Position: Q1 2017 in Review

Euclid Advisors sold out of Allergan plc (AGN) in Q1 2017, closing a stake of 1,416 shares — an estimated $297K sold.

Euclid Advisors first reported a position in AGN in Q2 2013 and held it in 14 quarters. The position peaked at $44.6M in Q1 2015. 1,104 funds tracked by Wall St. Rank hold AGN as of Q1 2017.

  • Euclid Advisors reported no remaining Allergan plc position as of Q1 2017 after selling out during the quarter.
  • Euclid Advisors sold 1,416 Allergan plc shares in Q1 2017, an estimated $297K.
  • Euclid Advisors first reported a position in Allergan plc in Q2 2013 and held it in 14 quarters.
  • Euclid Advisors's Allergan plc position peaked at $44.6M in Q1 2015.
  • 1,104 funds tracked by Wall St. Rank held Allergan plc as of Q1 2017.

Based on Euclid Advisors's 13F filing for Q1 2017.